IP Verse

Alnylam Pharmaceuticals, Inc. V. Pfizer Inc. - 1:23-cv-00578

Explore the details of the Alnylam Pharmaceuticals, Inc. V. Pfizer Inc. case under case number 1:23-cv-00578 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:23-cv-00578
Filing Date
May 26, 2023
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent

Parties Involved in the Case

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Pfizer Inc. -
BioNTech Manufacturing GmbH -
Pharmacia & Upjohn Co. LLC -
Alnylam Pharmaceuticals, Inc. -

Patents Involved in the Case

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Feb 21, 2025REDACTED VERSION of 424 Declaration by BioNTech Manufacturing GmbH, BioNTech SE. (Attachments: # 1 Exhibit 6, # 2 Exhibit 7, # 3 Exhibit 8)(Tigan, Jeremy) (Entered: 02/21/2025)PACER Document
Feb 24, 2025SO ORDERED, re 439 STIPULATION of Dismissal Regarding the '480 Patent. Signed by Judge Colm F. Connolly on 2/24/2025. (mws) (Entered: 02/24/2025)PACER Document
Mar 7, 2025ORAL ORDER: It is HEREBY ORDERED that the deadline for the parties to submit the proposed pretrial order is moved to May 30, 2025. Reset Scheduling Order Deadlines: (Proposed Pretrial Order due by 5/30/2025). Ordered by Judge Colm F. Connolly on 3/7/2025. (mws)PACER Document
Mar 25, 2025MOTION for Pro Hac Vice Appearance of Attorney Matthew Freimuth - filed by Pfizer Inc., Pharmacia & Upjohn Co. LLC. (Silverstein, Alan) (Entered: 03/25/2025)PACER Document
Mar 25, 2025Pro Hac Vice Fee - Credit Card Payment received for Matthew Freimuth. ( re 443 MOTION for Pro Hac Vice Appearance of Attorney Matthew Freimuth )( Payment of $ 50, receipt number ADEDC-4645133).(Silverstein, Alan) (Entered: 03/25/2025)PACER Document
Mar 25, 2025SO ORDERED, re 443 MOTION for Pro Hac Vice Appearance of Attorney Matthew Freimuth, filed by Pfizer Inc., Pharmacia & Upjohn Co. LLC. Ordered by Judge Colm F. Connolly on 3/25/2025. (kmd)PACER Document
Mar 25, 2025Pro Hac Vice Attorney Matthew Freimuth for Pfizer Inc. and Pharmacia & Upjohn Co. LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (cdd)PACER Document
Apr 28, 2025MEMORANDUM ORDER: Alnylam's Motion under O2 Micro for Resolution of the Claim Construction Dispute and/or Partial Daubert Motion for Dr. Steven R. Little (D.I. 292 ) is DENIED. Signed by Judge Colm F. Connolly on 4/28/2025. (mws) (Main Document 445 replaced on 5/1/2025) (mws). (Entered: 04/28/2025)PACER Document
Apr 28, 2025ORDER: Defendants' Motion for Summary Judgment of Literal Noninfringement for "Head Group" (D.I. 285) is DENIED. Signed by Judge Colm F. Connolly on 4/28/2025. (mws) (Entered: 04/28/2025)PACER Document
Apr 29, 2025ORDER: Defendants' Motion for Summary Judgment of Invalidity under 35 U.S.C. § 112 (D.I. 289 ) is DENIED. Signed by Judge Colm F. Connolly on 4/29/2025. (mws) (Entered: 04/29/2025)PACER Document
May 1, 2025Remark: page 3 of D.I. 445 replaced to correct typographical error. (mws)PACER Document
May 13, 2025Unopposed MOTION to Stay re 369 Answering Brief in Opposition, 299 MOTION for Summary Judgment of Noninfringement Based on Cationic Lipid Limitations (No. 4), 445 Memorandum and Order, [Unopposed Motion to Stay Pending Case Deadlines and Notice of Non-Opposition to Defendants' Motion for Summary Judgment of Noninfringement Based on "Cationic Lipid" Limitations (Summary Judgment Motion No. 4] - filed by Alnylam Pharmaceuticals, Inc.. (Attachments: # 1 Text of Proposed Order Granting Plaintiff Alnylam's Motion to Stay)(Townsend, Ethan) (Entered: 05/13/2025)PACER Document
May 13, 2025SO ORDERED, re 448 Unopposed MOTION to Stay. CASE STAYED. Signed by Judge Colm F. Connolly on 5/13/2025. (mws) (Entered: 05/13/2025)PACER Document
May 13, 2025Remark, re 449 SO ORDERED: the 6/18/2025 Pretrial Conference and 7/7/2025 Jury Trial are cancelled (mws)PACER Document
May 13, 2025Unopposed MOTION to Stay re 369 Answering Brief in Opposition, 299 MOTION for Summary Judgment of Noninfringement Based on Cationic Lipid Limitations (No. 4), 445 Memorandum and Order, [Unopposed Motion to Stay Pending Case Deadlines and Notice of Non-Opposition to Defendants' Motion for Summary Judgment of Noninfringement Based on "Cationic Lipid" Limitations (Summary Judgment Motion No. 4] - filed by Alnylam Pharmaceuticals, Inc.. (Attachments: # 1 Text of Proposed Order Granting Plaintiff Alnylam's Motion to Stay)(Townsend, Ethan) (Entered: 05/13/2025)Attachment
Feb 21, 2025REDACTED VERSION of 424 Declaration by BioNTech Manufacturing GmbH, BioNTech SE. (Attachments: # 1 Exhibit 6, # 2 Exhibit 7, # 3 Exhibit 8)(Tigan, Jeremy) (Entered: 02/21/2025)Attachment
Feb 21, 2025REDACTED VERSION of 424 Declaration by BioNTech Manufacturing GmbH, BioNTech SE. (Attachments: # 1 Exhibit 6, # 2 Exhibit 7, # 3 Exhibit 8)(Tigan, Jeremy) (Entered: 02/21/2025)Attachment
Feb 21, 2025REDACTED VERSION of 424 Declaration by BioNTech Manufacturing GmbH, BioNTech SE. (Attachments: # 1 Exhibit 6, # 2 Exhibit 7, # 3 Exhibit 8)(Tigan, Jeremy) (Entered: 02/21/2025)Attachment